Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Copy Top Investors Portfolio
Crypto Technical Analysis
Chart Pattern Signal

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. DNA
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
DNA
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

DNA Price Prediction Next Week

Technical Analysis: Based on the technical indicators, DNA stock shows mixed signals. The RSI(14) at 64.27 indicates the stock is approaching but not yet in overbought territory. The MACD at 0.74 suggests a positive momentum. The 20-day SMA at 10.61 and 60-day SMA at 9.29 forms an upward trend channel.

News and Event Analysis: Several significant events have occurred recently:

  • On January 16, 2025, Ginkgo Bioworks presented at the J.P. Morgan Healthcare Conference
  • A major $54M payment from the Department of Health and Human Services was received on January 17, 2025, for their Traveler-Based Genomic Surveillance Program
  • The company disclosed $70,000 in lobbying efforts for Q4 2024

Institutional Activity: Recent institutional activity shows concerning signals:

  • Only 19 institutional investors increased positions while 219 decreased their holdings
  • Insider trading activity shows 12 sales and 0 purchases over the past six months

Price Prediction for Next Week: Based on Fibonacci levels:

  • Support levels: S1 at $8.94, S2 at $7.58
  • Resistance levels: R1 at $13.38, R2 at $14.74
  • Pivot point: $11.16

Given the technical indicators, news events, and institutional activity, the stock is likely to test the first resistance level at $13.38. However, the heavy institutional selling pressure and lack of insider buying suggest limited upside potential.

Trading Recommendation: SELL

  • Current institutional selling pressure and lack of insider confidence indicate potential downside risks
  • While technical indicators show some positive momentum, the risk-reward ratio is unfavorable at current levels
  • Target exit price: $13.00-13.38 range
  • Stop loss: $8.94 (S1 level)

Technical Analysis: Based on the technical indicators, DNA stock shows mixed signals. The RSI(14) at 64.27 indicates the stock is approaching but not yet in overbought territory. The MACD at 0.74 suggests a positive momentum. The 20-day SMA at 10.61 and 60-day SMA at 9.29 forms an upward trend channel.

News and Event Analysis: Several significant events have occurred recently:

  • On January 16, 2025, Ginkgo Bioworks presented at the J.P. Morgan Healthcare Conference
  • A major $54M payment from the Department of Health and Human Services was received on January 17, 2025, for their Traveler-Based Genomic Surveillance Program
  • The company disclosed $70,000 in lobbying efforts for Q4 2024

Institutional Activity: Recent institutional activity shows concerning signals:

  • Only 19 institutional investors increased positions while 219 decreased their holdings
  • Insider trading activity shows 12 sales and 0 purchases over the past six months

Price Prediction for Next Week: Based on Fibonacci levels:

  • Support levels: S1 at $8.94, S2 at $7.58
  • Resistance levels: R1 at $13.38, R2 at $14.74
  • Pivot point: $11.16

Given the technical indicators, news events, and institutional activity, the stock is likely to test the first resistance level at $13.38. However, the heavy institutional selling pressure and lack of insider buying suggest limited upside potential.

Trading Recommendation: SELL

  • Current institutional selling pressure and lack of insider confidence indicate potential downside risks
  • While technical indicators show some positive momentum, the risk-reward ratio is unfavorable at current levels
  • Target exit price: $13.00-13.38 range
  • Stop loss: $8.94 (S1 level)

DNA Similar Chart Price Prediction

The price of DNA is predicted to go up -1.42%, based on the high correlation periods with KELYB. The similarity of these two price pattern on the periods is 93.45%.

stocks logo

DNA

stocks logo

KELYB

Down: -1.42%Similarity: 93.45%

DNA Stock Forecast & Prediction For Years 2025, 2026, 2027, 2028, 2029 and 2030

Year

DNA Price Forecast($)

Potential Return(%)

2025

9.730

-0.460

2026

9.730

-0.460

2027

15.000

53.450

2028

15.000

53.450

2029

15.000

53.450

2030

9.730

-0.460

What is DNA stock price prediction 2025 ?

DNA stock is currently trading at $9.73, reflecting a significant decline of 11.97% in regular market trading today. Based on recent performance, analyst ratings, and financial challenges, the 2025 price prediction for DNA stock is approximately $6-$8. This projection considers ongoing restructuring efforts, mixed revenue performance, and a cautious outlook from analysts.

What is DNA stock price prediction 2026 ?

DNA stock is currently trading at $9.73, with a significant decline of 11.97% in the regular market today. Based on its recent performance, restructuring efforts, and mixed revenue growth, the 2026 price prediction for DNA stock is estimated at $12.50. This projection assumes moderate recovery driven by improved profitability and biosecurity segment growth, but risks remain due to restructuring challenges and market volatility.

What is DNA stock price prediction 2027 ?

DNA stock is projected to reach $15 by 2027, driven by its strategic focus on biosecurity and cell engineering, which are expected to yield steady revenue growth. The company's ongoing restructuring efforts and cost management are likely to improve profitability, supporting long-term valuation. However, risks include market competition and execution challenges in scaling its operations.

What is DNA stock price prediction 2028 ?

The price prediction for DNA stock in 2028 is estimated to be around $15. This projection is based on potential growth from its bioengineering contracts, restructuring efforts, and improving financial metrics, despite current challenges. However, achieving this target depends on successful execution of its strategies and market conditions.

What is DNA stock price prediction 2029 ?

DNA stock's price prediction for 2029 is estimated at $15. This projection is based on the company's ongoing restructuring efforts, potential growth in its biosecurity and cell engineering segments, and its ability to secure contracts like the $9.4 million deal with Carnegie Mellon University. However, challenges in profitability and market competition may limit upside potential.

What is DNA stock price prediction 2030 ?

DNA stock is currently trading at $9.73, reflecting a significant decline in recent performance. By 2030, the stock price could potentially reach $15-$20, assuming successful execution of its bioengineering projects and improved profitability. However, risks like restructuring challenges and market competition may limit growth.

DNA Revenue Forecast

DNA EPS Forecast

DNA FAQs

What is bull‘s view on DNA?

DNA stock is currently trading at $9.28, with a bullish view targeting $10 based on Morgan Stanley's price target, supported by restructuring efforts and biosecurity segment growth. The recent $9.4M contract with Carnegie Mellon University for bioelectronic devices adds potential upside by showcasing innovation in cell engineering. However, the stock's recovery depends on sustained revenue growth and cost management.

What is bear's view on DNA?

DNA stock currently trades at $9.28, with bearish sentiment driven by significant challenges. The company faces restructuring pressures and underperformance in its Cell Engineering segment, limiting short-term growth potential. Additionally, its stock has declined 87% in 2024, reflecting weak investor confidence despite revenue growth from one-time effects.

What is DNA revenue forecast for next quarter？

The market consensus for DNA's revenue in the upcoming quarter is projected to be approximately $44.243M USD.

DNA VS S&P500

Ask Intellectia about DNA

DNA Analyst's Forecast

Brendan Smith

TD Cowen

Strong Buy

Price Target

$3 → $10

Upside

+24.84%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2024 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free